Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy (CIPN) at the AACR 2024 Annual Meeting
Stock Information for Sonnet BioTherapeutics Holdings Inc.
Loading
Please wait while we load your information from QuoteMedia.